| RS1599189718 |
SMAD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Juvenile polyposis syndrome, Hereditary cancer-predisposing syndrome |
| RS1599193093 |
CLPP
|
Health Risk |
Likely pathogenic |
Perrault syndrome 3, Perrault syndrome 3 |
| RS1599195400 |
SMAD4
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Hereditary cancer-predisposing syndrome |
| RS1599195433 |
SMAD4
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1599195489 |
SMAD4
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS1599196891 |
SMAD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Juvenile polyposis syndrome |
| RS1599196995 |
SMAD4
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1599197105 |
SMAD4
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS1599204042 |
SMAD4
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Hereditary cancer-predisposing syndrome |
| RS1599204121 |
SMAD4
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS1599204140 |
SMAD4
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Hereditary cancer-predisposing syndrome |
| RS1599205483 |
SMAD4
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS1599210325 |
PTBP1
|
Health Risk |
Pathogenic |
PTBP1-related neurodevelopmental disorder with skeletal dysplasia, STAD SYNDROME |
| RS1599230814 |
TRIM37
|
Health Risk |
Likely pathogenic |
Mulibrey nanism syndrome, Mulibrey nanism syndrome |
| RS1599253207 |
MCOLN1
|
Health Risk |
Likely pathogenic |
— |
| RS1599253805 |
NAGLU
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-III-B |
| RS1599253815 |
NAGLU
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-B |
| RS1599254152 |
MCOLN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS1599255682 |
MCOLN1
|
Health Risk |
Likely pathogenic |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS1599255987 |
NAGLU
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-III-B |
| RS1599258487 |
NAGLU
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-III-B |
| RS1599260473 |
NAGLU
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-III-B |
| RS1599276830 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS1599276914 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 42 |
| RS1599276954 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS1599289383 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS1599290793 |
ELANE
|
Health Risk |
Likely pathogenic |
ELANE-related disorder, ELANE-related disorder |
| RS1599292506 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Migraine, familial hemiplegic |
| RS1599292631 |
CACNA1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Episodic ataxia type 2, Episodic ataxia type 2 |
| RS1599294284 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS1599294750 |
ELANE
|
Health Risk |
Pathogenic |
Cyclical neutropenia, Neutropenia |
| RS1599305317 |
PNPLA6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 39, Hereditary spastic paraplegia 39 |
| RS1599307313 |
MAP2K2
|
Health Risk |
Likely pathogenic |
Cardio-facio-cutaneous syndrome, Cardio-facio-cutaneous syndrome |
| RS1599328119 |
TYK2
|
Health Risk |
Likely pathogenic |
— |
| RS1599335132 |
GALK1
|
Health Risk |
Likely pathogenic |
Deficiency of galactokinase, Deficiency of galactokinase |
| RS1599335144 |
GALK1
|
Health Risk |
Pathogenic |
Deficiency of galactokinase, Deficiency of galactokinase |
| RS1599336146 |
GALK1
|
Health Risk |
Likely pathogenic |
Deficiency of galactokinase, Deficiency of galactokinase |
| RS1599337939 |
MAN2B1
|
Health Risk |
Pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS1599338484 |
MAN2B1
|
Health Risk |
Pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS1599341718 |
DNMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant cerebellar ataxia, deafness and narcolepsy |
| RS1599344532 |
MAN2B1
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS1599346495 |
DNMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary sensory neuropathy-deafness-dementia syndrome, Hereditary sensory neuropathy-deafness-dementia syndrome |
| RS1599349822 |
MAN2B1
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS1599350640 |
MAN2B1
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS1599352199 |
MAN2B1
|
Health Risk |
Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS1599359239 |
NOTCH3
|
Health Risk |
Pathogenic |
Lateral meningocele syndrome, Lateral meningocele syndrome |
| RS1599359388 |
NOTCH3
|
Health Risk |
Pathogenic |
— |
| RS1599364162 |
ASXL3
|
Health Risk |
Likely pathogenic |
— |
| RS1599366076 |
DNMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary sensory neuropathy-deafness-dementia syndrome, Charcot-Marie-Tooth disease |
| RS1599366421 |
DNMT1
|
Health Risk |
Likely pathogenic |
Hereditary sensory neuropathy-deafness-dementia syndrome, Hereditary sensory neuropathy-deafness-dementia syndrome |
| RS1599366542 |
DNMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary sensory neuropathy-deafness-dementia syndrome, Inborn genetic diseases |
| RS1599367044 |
SETBP1
|
Health Risk |
Likely pathogenic |
Lymphoma, Lymphoma |
| RS1599367236 |
SETBP1
|
Health Risk |
Pathogenic |
— |
| RS1599367726 |
SETBP1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1599368029 |
SETBP1
|
Health Risk |
Pathogenic |
— |
| RS1599368323 |
SETBP1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 29 |
| RS1599368734 |
SETBP1
|
Health Risk |
Pathogenic |
Abnormality of the nervous system, Abnormality of the nervous system |
| RS1599375711 |
TCF4
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS1599377405 |
TCF4
|
Health Risk |
Likely pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS1599382214 |
NOTCH3
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebral arteriopathy, autosomal dominant |
| RS1599387121 |
NOTCH3
|
Health Risk |
Likely pathogenic |
Progressive psychomotor deterioration, Progressive psychomotor deterioration |
| RS1599389041 |
STXBP2
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis 5 |
| RS1599389393 |
NOTCH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cerebral arteriopathy, autosomal dominant |
| RS1599391536 |
NOTCH3
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebral arteriopathy, autosomal dominant |
| RS1599391938 |
NOTCH3
|
Health Risk |
Likely pathogenic |
Abnormal cerebral white matter morphology, Migraine with aura |
| RS1599391986 |
NOTCH3
|
Health Risk |
Pathogenic |
Migraine with aura, Depression |
| RS1599394351 |
NOTCH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cerebral arteriopathy, autosomal dominant |
| RS1599394654 |
NOTCH3
|
Health Risk |
Likely pathogenic |
NOTCH3-related disorder, NOTCH3-related disorder |
| RS1599394806 |
NOTCH3
|
Health Risk |
Pathogenic |
Cerebral arteriopathy, autosomal dominant |
| RS1599395085 |
STXBP2
|
Health Risk |
Pathogenic |
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL |
| RS1599395616 |
NOTCH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Myofibromatosis, infantile |
| RS1599397070 |
STXBP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis |
| RS1599398298 |
STXBP2
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis 5 |
| RS1599405952 |
TUBB4A
|
Health Risk |
Likely pathogenic |
Hypomyelinating leukodystrophy 6, Hypomyelinating leukodystrophy 6 |
| RS1599413207 |
TCF3
|
Health Risk |
Likely pathogenic |
Multiple myeloma, Multiple myeloma |
| RS1599414759 |
UNC13D
|
Health Risk |
Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis 3, Familial hemophagocytic lymphohistiocytosis 3 |
| RS1599426021 |
EPG5
|
Health Risk |
Likely pathogenic |
EPG5-related disorder, EPG5-related disorder |
| RS1599439595 |
LONP1
|
Health Risk |
Likely pathogenic |
CODAS syndrome, CODAS syndrome |
| RS1599445663 |
EPG5
|
Health Risk |
Pathogenic |
Vici syndrome, Vici syndrome |
| RS1599447883 |
EPG5
|
Health Risk |
Pathogenic |
Vici syndrome, Vici syndrome |
| RS1599473950 |
BRD4
|
Health Risk |
Likely pathogenic |
Short stature, Short stature |
| RS1599474108 |
EPG5
|
Health Risk |
Pathogenic |
Vici syndrome, Vici syndrome |
| RS1599475959 |
LONP1
|
Health Risk |
Pathogenic |
— |
| RS1599518940 |
C3
|
Health Risk |
Likely pathogenic |
Complement component 3 deficiency, Complement component 3 deficiency |
| RS1599520660 |
PIGN
|
Health Risk |
Likely pathogenic |
Multiple congenital anomalies-hypotonia-seizures syndrome 1, Multiple congenital anomalies-hypotonia-seizures syndrome 1 |
| RS1599525360 |
PIGN
|
Health Risk |
Likely pathogenic |
Multiple congenital anomalies-hypotonia-seizures syndrome 1, Multiple congenital anomalies-hypotonia-seizures syndrome 1 |
| RS1599531710 |
PIGN
|
Health Risk |
Pathogenic |
Multiple congenital anomalies-hypotonia-seizures syndrome 1, Multiple congenital anomalies-hypotonia-seizures syndrome 1 |
| RS1599534276 |
C19orf12
|
Health Risk |
Pathogenic |
Neurodegeneration with brain iron accumulation 4, Neurodegeneration with brain iron accumulation 4 |
| RS1599534394 |
C19orf12
|
Health Risk |
Pathogenic |
Neurodegeneration with brain iron accumulation 4, Neurodegeneration with brain iron accumulation 4 |
| RS1599536432 |
EPG5
|
Health Risk |
Likely pathogenic |
Vici syndrome, Vici syndrome |
| RS1599554145 |
PIGN
|
Health Risk |
Pathogenic |
— |
| RS1599555124 |
IL12RB1
|
Health Risk |
Pathogenic |
Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency, Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency |
| RS1599560256 |
GTPBP3
|
Health Risk |
Pathogenic/Likely pathogenic |
Combined oxidative phosphorylation defect type 23, Combined oxidative phosphorylation defect type 23 |
| RS1599562180 |
ASXL3
|
Health Risk |
Pathogenic |
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome, Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome |
| RS1599563269 |
ASXL3
|
Health Risk |
Likely pathogenic |
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome, Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome |
| RS1599563619 |
ASXL3
|
Health Risk |
Pathogenic |
— |
| RS1599563995 |
ASXL3
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome, Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome |
| RS1599564118 |
ASXL3
|
Health Risk |
Pathogenic |
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome, Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome |
| RS1599565958 |
ASXL3
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS1599566942 |
ASXL3
|
Health Risk |
Likely pathogenic |
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome, Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome |